Skip to main content
Log in

Association of the IRF5 rs2070197 polymorphism with systemic lupus erythematosus: a meta-analysis

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to explore whether the interferon regulatory factor 5 (IRF5) gene rs2070197 polymorphism was associated with systemic lupus erythematosus (SLE) in multiple ethic populations. A meta-analysis was conducted on the C allele of the IRF5 rs2070197 polymorphism. A total of 7 published case–control studies with 12 comparisons involving 8171 SLE patients and 8904 controls were available for this meta-analysis. This meta-analysis demonstrated the IRF5 rs2070197 polymorphism conferred susceptibility to SLE in all subjects (odds ratio (OR) = 2.128, 95 % confidence interval (CI): 1.856–2.441, P < 0.001) without inter-study heterogeneity. The IRF5 rs2070197 polymorphism was identified as risk factors for SLE in Caucasian populations (OR 1.82, 95 % CI 1.70–1.96), but it had no effects (monomorphic) in Asians. Large-scale multicenter epidemiological studies in selected populations with other risk factors were urgently required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bae SC, Fraser P, Liang MH (1998) The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the “prevalence gradient hypothesis”. Arthritis Rheum 41(12):2091–2099

    Article  CAS  PubMed  Google Scholar 

  2. Wakeland EK et al (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15(3):397–408

    Article  CAS  PubMed  Google Scholar 

  3. Nath SK, Kilpatrick J, Harley JB (2004) Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 16(6):794–800

    Article  CAS  PubMed  Google Scholar 

  4. Deng Y, Tsao BP (2010) Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 6(12):683–692

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Banchereau J, Pascual V (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25(3):383–392

    Article  CAS  PubMed  Google Scholar 

  6. Niewold TB et al (2010) Interferon alpha in systemic lupus erythematosus. J Biomed Biotechnol 2010:948364

    Article  PubMed Central  PubMed  Google Scholar 

  7. Blanco P et al (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294(5546):1540–1543

    Article  CAS  PubMed  Google Scholar 

  8. Kariuki SN et al (2009) Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 182(1):34–38

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Graham RR et al (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38(5):550–555

    Article  CAS  PubMed  Google Scholar 

  10. Sigurdsson S et al (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 17(6):872–881

    Article  CAS  PubMed  Google Scholar 

  11. Kavanagh D et al (2008) New roles for the major human 3′-5′ exonuclease TREX1 in human disease. Cell Cycle 7(12):1718–1725

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Sigurdsson S et al (2008) A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet 17(18):2868–2876

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Abelson AK et al (2009) STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 68(11):1746–1753

    Article  CAS  PubMed  Google Scholar 

  14. Takaoka A et al (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434(7030):243–249

    Article  CAS  PubMed  Google Scholar 

  15. Couzinet A et al (2008) A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis. Proc Natl Acad Sci U S A 105(7):2556–2561

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Lien C et al (2010) Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A 107(10):4664–4668

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Savitsky DA et al (2010) Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc Natl Acad Sci U S A 107(22):10154–10159

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Barnes BJ, Moore PA, Pitha PM (2001) Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 276(26):23382–23390

    Article  CAS  PubMed  Google Scholar 

  19. Schoenemeyer A et al (2005) The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem 280(17):17005–17012

    Article  CAS  PubMed  Google Scholar 

  20. Taniguchi T et al (2001) IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623–655

    Article  CAS  PubMed  Google Scholar 

  21. Hughes T et al (2012) Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis Rheum 64(2):485–492

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Reddy MV et al (2007) Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet 121(6):721–727

    Article  PubMed  Google Scholar 

  23. Fourati H et al. (2102) Genetic factors contributing to systemic lupus erythematosus in Tunisian patients.J Clin Cell Immunol 03(04)

  24. Lofgren SE et al (2010) Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. J Rheumatol 37(3):574–578

    Article  PubMed  Google Scholar 

  25. Kozyrev SV et al (2007) Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56(4):1234–1241

    Article  CAS  PubMed  Google Scholar 

  26. Kelly JA et al (2008) Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 9(3):187–194

    Article  CAS  PubMed  Google Scholar 

  27. Graham RR et al (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104(16):6758–6763

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Siu HO et al (2008) Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese. J Rheumatol 35(2):360–362

    CAS  PubMed  Google Scholar 

  29. Shin HD et al (2008) Different genetic effects of interferon regulatory factor 5 (IRF5) polymorphisms on systemic lupus erythematosus in a Korean population. J Rheumatol 35(11):2148–2151

    Article  CAS  PubMed  Google Scholar 

  30. Cunninghame GD et al (2007) Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum Mol Genet 16(6):579–591

    Google Scholar 

  31. Hughes T et al (2012) Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Ann Rheum Dis 71(5):694–699

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Hom G et al (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358(9):900–909

    Article  CAS  PubMed  Google Scholar 

  33. Hu W, Ren H (2011) A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus. Int J Immunogenet 38(5):411–417

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all our colleagues working in the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology.

Disclosures

None.

Funding

This work was supported by funding from the Research Special Fund for Public Welfare Industry of Health (201202004), and the National Natural Science Foundation of China Grants (81172857,81373188), and the Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grants (2011AA02A113).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yongzhe Li.

Additional information

Yuan Li, Si Chen and Ping Li contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Chen, S., Li, P. et al. Association of the IRF5 rs2070197 polymorphism with systemic lupus erythematosus: a meta-analysis. Clin Rheumatol 34, 1495–1501 (2015). https://doi.org/10.1007/s10067-015-3036-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-3036-5

Keywords

Navigation